Gerresheimer AG (ETR:GXI – Get Free Report) was up 0.9% on Wednesday . The stock traded as high as €69.45 ($70.87) and last traded at €69.45 ($70.87). 202,264 shares traded hands during mid-day trading, an increase of 44% from the average session volume of 140,925 shares. The stock had previously closed at €68.85 ($70.26).
Gerresheimer Trading Down 0.2 %
The business’s 50 day simple moving average is €73.89 and its 200-day simple moving average is €87.71. The stock has a market capitalization of $2.38 billion, a P/E ratio of 20.72, a PEG ratio of 0.82 and a beta of 0.94. The company has a debt-to-equity ratio of 79.36, a current ratio of 0.87 and a quick ratio of 0.40.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Recommended Stories
- Five stocks we like better than Gerresheimer
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- With Risk Tolerance, One Size Does Not Fit All
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.